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The Drosophila nuclear lamina protein YA is essential for the transition from female meiosis to embryo mitosis. Its
localization and, hence, function is under developmental and cell cycle controls. YA protein is hyperphosphorylated and
cytoplasmic in ovaries. Upon egg activation, YA is partially dephosphorylated and acquires the ability to enter nuclei. Its
function is first detected at this time. To investigate the cytoplasmic retention machinery that keeps YA from entering
nuclei, we used affinity chromatography and blot overlay assays to identify cytoplasmic proteins that associate with YA.
Drosophila P0/AP3, a ribosomal protein that is also an apurinic/apyrimidinic endonuclease, binds to YA in ovary and
embryo cytoplasms. P0 and YA bind specifically and directly in vitro and are present in a 20S complex in the cytoplasmic
extracts. YA protein can be phosphorylated by MAPK, but not by p34Cdc2 kinase, in vitro. This phosphorylation increases
YA’s binding to P0. We propose that the P0-containing 20S cytoplasmic complex retains hyperphosphorylated ovarian YA
in the cytoplasm. In response to egg activation, YA is partially dephosphorylated and its binding to the 20S complex is
reduced. Hence, some YA dissociates from the complex and enters nuclei. Consistent with this model, decreasing P0 levels
partially suppress a hypomorphic Ya mutant allele. © 2002 Elsevier Science (USA)
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Oocyte growth, maturation, and activation are critical
processes for successful production of an embryo. During
oogenesis, oocytes stockpile mRNAs and proteins that will
be used subsequently for embryo development. During
oocyte maturation, oocytes acquire the capability to be
activated and fertilized. Mature oocytes in all vertebrates
and many invertebrates, including Drosophila, arrest dur-
ing meiotic metaphase awaiting egg-activation signals. Egg
activation triggers completion of meiosis, allowing the
formation of a haploid female pronucleus that can partici-
pate in further development. In several organisms, the
phosphorylation states of some maternal proteins undergo
changes that are important for proper progression through
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All rights reserved.oocyte maturation, metaphase arrest, and egg activation.
For example, inhibition of phosphorylation of maternal
proteins during meiotic metaphase arrest can activate Xe-
nopus eggs (Zhang and Masui, 1992), suggesting that phos-
phorylation of maternal proteins is essential to maintain
the meiotic metaphase arrest.
Maturation promoting factor (MPF; p34Cdc2 kinase and
cyclin B complex) and mitogen-activated protein kinase
(MAPK) are two key kinases during these processes. In most
invertebrates and vertebrates (e.g., the bivalve Ruditape,
ascidians, Xenopus, mouse), MPF and MAPK activities
increase during oocyte maturation, remain high during
oocyte metaphase arrest, and decrease after initiation of egg
activation (Colas and Guerrier, 1995; Russo et al., 1998).
MPF activity is required for oocyte maturation and the
maintenance of meiotic arrest, and its inactivation is essen-
tial for egg activation (Colas and Guerrier, 1995; Palmer and
Nebreda, 2000). MPF is responsible for chromatin conden-
sation and nuclear envelope disassembly during Xenopus
metaphase arrest (Lohka, 1998). In most organisms, MAPK
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is not required for germinal vesicle breakdown (GVBD) or
MPF activation during oocyte maturation, but is required
for the maintenance of oocyte metaphase arrest (Fisher et
al., 1999; Gross et al., 2000; Kosako et al., 1994a,b). In
Xenopus, a transient early high level of MAPK is required
for the correct timing and efficiency of GVBD, and MAPK
increases MPF activity (Fisher et al., 1999; Gross et al.,
2000). MAPK is required to suppress entry into S phase
between meiosis I and meiosis II (Gross et al., 2000) and
may trigger nuclear migration independent of MPF activity
during oocyte maturation (Gavin et al., 1999). MAPK is also
sufficient for MPF activation at the onset of oocyte matu-
ration (Gotoh et al., 1995; Haccard et al., 1995; Huang et al.,
1995; Yew et al., 1992). The situation in some other
organisms, such as Chaetopterus, is a bit different: MAPK is
neither required nor sufficient for oocyte maturation or
meiotic arrest (Eckberg, 1997). In mouse, high MAPK activ-
ity during oocyte maturation and metaphase arrest is im-
portant for the maintenance of chromosome condensation
and the metaphase block, formation of the meiotic spindles,
and prevention of pronuclear envelope formation (Choi et
al., 1996; Moos et al., 1995; Verlhac et al., 1994). The
phosphorylation targets of MAPK that execute these func-
tions are largely unknown, with the exception of p90Rsk,
which is phosphorylated by MAPK during Xenopus oocyte
maturation (Bhatt and Ferrell, 1999; Gavin et al., 1999;
Gross et al., 1999; Grove et al., 1993; Sturgill et al., 1988).
The role or modulation of MPF and MAPK in Drosophila
oocytes is as yet unknown. Drosophila oocytes arrest at
meiotic prophase I during most of oogenesis. Toward the
end of oogenesis, they resume meiosis, only to arrest again
at metaphase I (Page and Orr-Weaver, 1997). Egg activation
occurs independent of and prior to fertilization (Doane,
1960; Heifetz et al., 2001).
The YA (Young Arrest) phosphoprotein is essential for
nuclear events during the developmental transition from
female meiosis to embryo mitosis (Lin and Wolfner, 1991;
Liu et al., 1995; Yu et al., 1999). Embryos from females
lacking YA function arrest just after completing meiosis.
Zygotic mitosis never occurs in these embryos (Lin and
Wolfner, 1991; Liu et al., 1995; Lopez, 1996; Berman, 2000).
In normal embryos and activated oocytes, YA is found in
interphase through metaphase nuclei, in the nuclear lamina
layer of the nuclear envelope, where it associates with
lamin (Goldberg et al., 1998), and in the nucleoplasm,
where it associates with chromatin (Lopez and Wolfner,
1997) through its direct interaction with DNA and with
histone H2B (Yu and Wolfner, 2002). There is also a cyto-
plasmic pool of YA throughout the cell cycle. In ovaries, YA
is in a more highly phosphorylated form and is excluded
from oocyte nuclei, and away from chromatin (Yu et al.,
1999). Thus, only after egg activation does YA acquire its
ability to enter nuclei, coincident with its partial dephos-
phorylation. Based on this correlation, we proposed that
phosphorylation regulates YA’s potential for nuclear entry
during development (Yu et al., 1999).
YA contains five predicted MAPK target sites and four
predicted p34Cdc2 kinase target sites (Liu and Wolfner, 1998).
443Thr, which is both a p34Cdc2 kinase and MAPK predicted
target site, is one of at least two sites in YA that are
differentially phosphorylated during this developmental
transition (Yu et al., 1999). This suggests that phosphory-
lation of YA by one or both of these kinases may regulate
YA’s subcellular location.
Phosphorylation can regulate a protein’s nuclear entry by
modulating the protein’s interaction with cytoplasmic re-
tention machinery (Jans and Hubner, 1996). In one phos-
phorylation state, the target protein binds the cytoplasmic
retention machinery and stays in the cytoplasm. In another
phosphorylation state, the protein loses affinity for the
cytoplasmic retention machinery and can enter nuclei via
its nuclear localization signals (NLS). This type of regula-
tion is typified by the nuclear import of the Drosophila
Dorsal protein (Drier et al., 1999; Liu et al., 1997; Whalen
and Steward, 1993). Dorsal is retained in the cytoplasm by
binding to Cactus protein. In response to dorsoventral
signaling, Dorsal and Cactus are both phosphorylated, caus-
ing Dorsal to dissociate from Cactus and leading to Dorsal’s
nuclear entry.
Here, we present evidence that the changes in YA’s
subcellular localization may utilize an analogous mecha-
nism, but one regulated during egg activation. We report
that YA binds to P0/AP3, a Drosophila ribosomal protein
which also has apurinic/apyrimidinic endonuclease activity
(Yacoub et al., 1996). In vitro, this interaction is influenced
by YA’s phosphorylation state: YA is a target of MAPK (but
not p34Cdc2 kinase) in vitro, and MAPK-phosphorylated YA
binds more strongly to P0 than YA that was not phosphor-
ylated by MAPK. We propose that MAPK phosphorylation
of YA in ovaries results in YA’s retention in the cytoplasm
within a 20S complex that also contains P0. Upon activa-
tion, dephosphorylation of YA releases it from the complex,
allowing it to enter nuclei. Consistent with this model,
lowering the levels of P0 partially suppresses a hypomor-
phic Ya mutant allele. YA provides a molecular probe with
which to assess the cause and consequences of phosphory-
lation changes during Drosophila egg activation.
MATERIALS AND METHODS
Production, Purification, and Coupling of
Recombinant Proteins
To make a protein fusion of YA to a tag [E. coli maltose-binding
protein (MBP)] and a site to allow labeling in vitro [a heart-muscle
kinase (HMK) target site (Blanar and Rutter, 1992)], full-length Ya
cDNA (Lopez et al., 1994) was cloned into a modified pMALTM-c2
vector (NEB) called pMALC2-HMK(R) (Z. Li and M. L. Goldberg,
personal communication). The fusion protein is called MBP-HMK-
YA. A full-length P0 cDNA (Yacoub et al., 1996) was cloned into
pET21a() vector (Novagen) to express P0-His6 fusion protein.
Protein induction and expression were done according to NEB’s
protein fusion and purification (pMALTM) instruction manual (for
MBP-HMK-YA) or the pET system manual (Novagen) (for P0-His6)
with the following modifications. The construct was transformed
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into Escherichia coli BL21(DE3)pLysS cells (for MBP-HMK-YA) or
BL21(DE3) (for P0-His6). An overnight culture was diluted 1:20 into
fresh medium. IPTG was added to a final concentration of 1 mM
(for MBP-HMK-YA) or 0.4 mM (for P0-His6). All the following steps
after harvest of cells were performed at 4°C. The cell pellet was
immediately resuspended and sonicated. Triton X-100 was added to
the cell lysate to a final concentration of 1%. The lysate was
incubated for 1 h with continuous mixing, and centrifuged at
39,000g for 30 min. MBP-HMK-YA was purified from the superna-
tant with amylose beads, and P0-His6 was purified with His-bind
beads (Novagen). The peak fractions were pooled and analyzed by
7.5% SDS–polyacrylamide gels with Coomassie blue staining and
Western blotting with affinity-purified anti-YA or anti-P0 antibod-
ies.
Like endogenous YA (Liu and Wolfner, 1998), purified MBP-
HMK-YA protein can interact with embryonic YA (data not
shown). MBP-HMK-YA can also be incorporated into the nuclear
envelope of in vitro assembled nuclei in Xenopus egg extracts
(M.F.W., unpublished observations), consistent with its being ca-
pable of at least some of YA’s normal behaviors.
A total of 4 mg of MBP-HMK or MBP-HMK-YA was coupled to
1 ml CNBr-activated Sepharose-4B beads (Sigma) following the
procedure from the manufacturer. The coupling efficiency was
above 90%, judging by SDS–PAGE.
Ovaries, Embryos, and Extracts for Column
Purification
Ovaries, eggs, and embryos from females of the Oregon R P2
strain (Allis et al., 1977) were used for all experiments. Ovaries
were dissected from 2-day-old virgin females into 1 EBR buffer
(Verheyen and Cooley, 1994) and ground in the indicated buffers.
Ovaries were in 1 EBR buffer for less than 15 min before grinding
to avoid activation of mature oocytes. Embryos at 0–2 h were
collected as described in Allis et al. (1977) and homogenized with
a Dounce homogenizer (tight pestle) in 1 vol of 1 Hyb(75) buffer
(20 mM Hepes–KOH, pH 7.7, 75 mM KCl, 0.1 mM EDTA, 2.5 mM
MgCl2, 1 mM DTT) with 0.5% NP-40. Protease inhibitors includ-
ing 1 mM PMSF, 1 g/ml leupeptin, 1 g/ml aprotinin, 1 g/ml
pepstatin A, and 1 g/ml antipain were included in all solutions.
All steps after tissue/embryo collection were done at 4°C. After
incubation on ice for 10 min, the homogenate was centrifuged at
20,000g for 10 min. The supernatant was diluted with 9 vol of 1
Hyb(75) buffer and incubated for 10 min. After another centrifuga-
tion, the supernatant was ready for MBP pull-down assay or for
column purification.
For column purification, embryo extracts were loaded through
an MBP-HMK-coupled affinity column. The flow-through was
loaded onto an MBP-HMK-YA-coupled affinity column. After
washing with 1 Hyb(75) buffer, proteins bound to the column
were eluted with 1Hyb(75) buffer with increasing concentrations
of NaCl from 0.1 to 1 M.
Blot Overlay Assay
To make probes, 2 g of MBP-HMK-YA or MBP-HMK was
incubated in a 100-l labeling reaction and incubated at room
temperature for 3 h (Blanar and Rutter, 1992). Labeling of proteins
was verified by SDS–PAGE followed by autoradiography.
Proteins to be analyzed by blot overlay assay were separated by
SDS–PAGE and transferred to nitrocellulose membranes as de-
scribed in Lin and Wolfner (1991). The blot overlay assay was
performed as Blanar and Rutter (1992) with minor modifications.
Protein Sequencing
Proteins for sequencing were separated on SDS–PAGE and trans-
ferred to PVDF membranes according to Lin and Wolfner (1991).
The membrane was stained with Coomassie blue and destained
with milliQ water. The band of interest was cut from the mem-
brane and sequenced from the protein’s N terminus with a PE/
Applied Biosystems Precise 492, by the Cornell University BioRe-
source Center. The unambiguous amino acids in the peptide
sequence thus obtained were used to search the nr database to
identify the protein.
Genomic PCR
The genomic region spanning the N-terminal coding sequence of
P0 from the Oregon R P2 strain was amplified with primers:
5-TTCTTAAATTCACCCGACGA-3 and 5-TGGTACGGATG-
TTCTGCATC-3 as described by Yu and Wolfner (2002). The
sequence of the PCR product was determined and compared with
the D. melanogaster genome sequence in Adams et al. (2000).
The Yeast Two-Hybrid Assay
Full-length P0 cDNA (a kind gift from M. Kelley; Yacoub et al.,
1996) was cloned into the pGAD424 vector. Full-length Ya cDNAs
that happened to carry mutations in the five potential MAPK
phosphorylation sites to glutamic acid (All-E) or to alanine (all-A)
(S. Mani and M.F.W., unpublished results) were cloned into pGBT9
vector as in Goldberg et al. (1998). The pGBT9-YA constructs were
cotransformed with pGAD424 (negative control), pGAD424-P0, or
pGAD424-lamin Dm0 (positive control; Goldberg et al., 1998) into
yeast strains HF7c and SFY526 -gal activity was assayed qualita-
tively (by color of the colonies; HF7c strains) and quantitatively (for
-Gal activity units; SFY526 strains) as described in Goldberg et al.
(1998). Each combination was tested in duplicate. -Gal units are
the average of three determinations per experiment; data from one
experiment per combination is shown.
Immunofluorescence staining
Embryos at 0–2 h were collected and processed as described in
Lin and Wolfner (1991). Embryos were incubated with affinity-
purified anti-P0 antibodies (1:50). Anti-P0 antibodies were purified
from crude antiserum kindly provided by M. R. Kelley (Yacoub et
al., 1996) by using a GST-P0 protein-coupled Sepharose 4B column.
The embryos were then stained with FITC-conjugated anti-rabbit
IgG antibodies (1:100) and counterstained with DAPI. Images were
collected by using laser scanning confocal microscopy (Bio-Rad
MRC 600 system on a Zeiss inverted microscope).
Coimmunoprecipitation Assay and Antibodies
Cytoplasmic extracts were made from 10 l of packed 0- to 1-h
embryos or from 80 ovaries dissected from 2-day-old virgin females.
To half the extracts, affinity-purified anti-P0 antibodies were
added; the other half received preimmune serum. After 2 h of
incubation, 10 l protein A-Sepharose CL-4B beads (Sigma) were
added and the mixture was rotated end-to-end for 6 h. The beads
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were then harvested and washed with 1 Hyb(75) with 0.05%
NP-40 eight times. Proteins were eluted from the beads by boiling
in SDS–PAGE sample buffer. One-twentieth of the supernatant
after binding and half the eluate from the beads were analyzed by
Western blotting with affinity-purified anti-P0 antibodies and
anti-YA antibodies.
For coimmunoprecipitation with anti-YA antibodies, 2 l of
affinity-purified anti-YA antibodies (Lin and Wolfner, 1991) were
added to cytoplasmic extracts from 5 l of packed 0- to 2-h embryo
from wild-type or Ya2 mutant females. Presence of YA and P0 in
samples corresponding to 1 l of embryos was assessed by Western
blotting; supernatant after binding and the eluate from the beads
were examined.
Sucrose Density Gradient Sedimentation Assay
Embryos at 0–2 h were homogenized in 4 vol of buffer D (50 mM
Tris–HCl, pH 7.5, 50 l MgCl2, 145 mM sucrose) with 100 mM
NaCl and 0.25% Triton X-100. The supernatant was loaded onto a
5–35% sucrose density gradient in the same buffer. Centrifugation
conditions were as described in Swanson and Vacquier (1997). The
collected fractions were precipitated with 2 vol of acetone. The
pellet was dissolved in 1 SDS–PAGE sample buffer, boiled for 5
min, and analyzed by Western blotting. All steps were performed at
4°C. Molecular weight markers (MW-GF-1000; Sigma) were run in
the sucrose density gradient at the same time and analyzed by
SDS–PAGE with silver staining. Purified polyclonal anti-DS3 was
provided by M. R. Kelley (Wilson et al., 1994).
MBP Pull-Down Assay
To test the specificity of the cytoplasmic proteins’ binding to
YA, extracts from 10 l of packed 0- to 2-h embryos were incubated
overnight with 20 l of either MBP-HMK-YA beads or MBP-HMK
beads in the absence or presence of 2 g MBP-HMK or MBP-HMK-
YA. The beads were then washed with 1 Hyb(75)  0.05% NP-40
eight times. Proteins bound to the beads were eluted with 1
Hyb(75)  0.05% NP-40  1 M NaCl.
To test purified P0’s direct binding to YA, 2 g of purified
MBP-HMK-YA or 2 g of purified MBP-HMK were incubated with
4 g of P0-His6 in 1 Hyb(75)  0.05%NP-40 with protease
inhibitors (1 mM PMSF, 1 g/ml leupeptin, 1 g/ml aprotinin, and
1 g/ml pepstatin) for 1 h. Amylose beads (30 l) were then added
to the solution, which was then rotated end-to-end for 5 h. After
centrifugation, the beads were harvested and washed four times
with 1 ml of 1 Hyb(75)  0.05% NP-40  200 mM NaCl with
protease inhibitors. The beads were eluted by boiling in 4
SDS–PAGE sample buffer for 5 min. The supernatant after the
binding was precipitated with 2 vol of acetone at 20°C overnight.
The pellet was dissolved in 1 SDS–PAGE sample buffer and
boiled for 5 min. The supernatant after binding and half of the
eluate from the beads were analyzed by SDS–PAGE followed by
Western blotting with affinity-purified anti-P0 antibodies. All steps
were performed at 4°C.
To test the effect of phosphorylation of YA on YA’s interaction
with P0, different dilutions of in vitro phosphorylated YA and
mock phosphorylated YA (0.7 or 0.3 g) were mixed with 3 g
P0-His6 in a final volume of 250 l containing 1 Hyb(75), 0.05%
NP-40, and protease inhibitors. The binding reaction was per-
formed as above.
Immunoprecipitation of p34Cdc2 Kinase from Hela
Cells
Cell culture, synchronization, and lysis of Hela S3 cells were
performed according to Resnick et al. (1997). All buffers following
cell lysis were supplemented with protease inhibitors and phospha-
tase inhibitors (25 mM NaF, 1 mM Na vanadate, 10 g/ml
leupeptin, 10 g/ml aprotinin). Anti-p34Cdc2 kinase antibodies (10
g) (Gibco Life Technologies) were added to cell lysates containing
about 500 g protein and incubated for 2 h at 4°C. Protein
A-Sepharose CL-4B beads (20 l; Sigma) were then added and the
mixture was rotated for 1 h at 4°C. The beads were harvested and
washed once with KLB (Resnick et al., 1997) three times and with
1 kinase buffer (NEB). The beads were then resuspended in 50 l
1 kinase buffer and stored at 4°C.
In Vitro Phosphorylation Reactions
MBP-HMK-YA fusion protein (0.5 g) or 1 g histone H1 in 1
kinase buffer was incubated with 2 l immunoprecipitated p34Cdc2
kinase or 0.5 l MAPK (ERK2, NEB) in a final volume of 25 l
containing 1 kinase buffer and 100 M ATP and 20 Ci/mmol
[-32P]ATP (final concentration). MBP-HMK-YA (4 g) was incu-
bated in a final volume of 100 l containing 1 kinase buffer and
200 M ATP with or without (mock phosphorylation) 14 l
immunoprecipitated p34Cdc2 kinase and/or 4 l MAPK. [-32P]ATP
was added to a 10-l aliquot of the above reaction mix to a final
concentration of 20 mCi/mol. All buffers were supplemented
with protease inhibitors and phosphatase inhibitors (25 mM NaF, 1
mM Na vanadate, 10 g/ml leupeptin, 10 g/ml aprotinin). All the
reactions were incubated at room temperature for 4 h with rota-
tion. The reactions with radioactive ATP were analyzed by SDS–
PAGE. Reactions with nonradioactive ATP were used for MBP
pull-down assays.
Genetic Suppression Analysis
P0306/MKRS stock was kindly provided by M. V. Frolov and J. A.
Birchler (Frolov and Birchler, 1998). X∧X, y Ya77 cv v f/Y, Ya y w
Bs (Liu et al., 1995) virgin females were mated with P0306/MKRS
males. Then, 0- to 2-h embryos were collected from X∧X, y Ya77 cv
v f/Y; P0306/, and X∧X, y Ya77 cv v f/Y; /MKRS females,
respectively. All embryos were stained with DNA dye DAPI and
examined with an Olympus BX50 equipped with a Pentamax
camera (Princeton Instruments). Three independent repeats of the
experiment gave comparable results. The results of one of those
experiments is shown.
RESULTS
Drosophila P0 Interacts with YA
To identify cytoplasmic proteins that interact with YA
and could serve as YA’s cytoplasmic retention machinery,
we employed a blot overlay assay to detect proteins that
interact with YA directly, and affinity chromatography to
purify those proteins. The same bands from ovary and
syncytial-stage embryo cytoplasmic samples were detected
by a 32P-labeled MBP-HMK-YA probe (data not shown),
suggesting that the same group of proteins from ovary and
embryo cytoplasm interact with YA. As it is easier to get
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large amounts of embryos for protein purification, embryos
rather than ovaries were used as starting material to purify
YA-interacting proteins from cytoplasm.
We then tested whether the proteins that bound to the
32P-labeled MBP-HMK-YA probe in the blot overlay assay
could bind to MBP-HMK-YA specifically and in a nondena-
tured condition suitable for affinity column purification.
Cytoplasmic extracts from 0- to 2-h embryos were incu-
bated with MBP-HMK-YA-coupled beads or MBP-HMK-
coupled beads in the presence or absence of excess amounts
of uncoupled MBP-HMK-YA or MBP-HMK protein (see
Material and Methods). Proteins bound to the beads were
eluted and analyzed by blot overlay assay. As shown in Fig.
1 of the blot probed with 32P-labeled MBP-HMK-YA probe,
in the presence of excess unlabelled MBP-HMK, six pro-
teins that bind to MBP-HMK-YA-coupled beads were de-
tected by the probe (Fig. 1, lane 2). Of these, three proteins,
P35, P12 and P10, did not bind to MBP-HMK-coupled beads
(Fig. 1, lane 1), suggesting that they only bound to the YA
moiety. P25 bound to MBP-HMK beads very weakly but to
MBP-HMK-YA beads strongly, suggesting that it has weak
nonspecific binding to MBP-HMK and/or the beads, but it
has strong affinity for YA. Confirming this, the binding of
P35, P25, P12, and P10 to MBP-HMK-YA-coupled beads was
competed by MBP-HMK-YA in solution (Fig. 1, lane 3), but
not by MBP-HMK in solution (Fig. 1, lane 4). The other two
proteins, P42 and P30, bound to both MBP-HMK-YA-
coupled beads and MBP-HMK-coupled beads (Fig. 1, lanes 1
and 2), suggesting that they could bind to the MBP-HMK,
YA moiety, and/or the beads. Their binding to MBP-
HMK-YA beads was competed by MBP-HMK-YA, but not
MBP-HMK, in solution (Fig. 1, lanes 3 and 4), suggesting
that they bound to both the YA moiety of MBP-HMK-YA
and the beads. Since P42 and P30 do not bind to YA
specifically, they were not studied further. The blot probed
with 32P-labeled MBP-HMK probe in the presence of excess
unlabeled MBP-HMK (Fig. 1) did not have any signal,
suggesting that the blockage by the nonlabeled MBP-HMK
of any potential 32P-labeled MBP-HMK probe’s binding to
the proteins on the blot is complete; it also confirms that
the signals from the blot probed with 32P-labeled MBP-
HMK-YA came from YA’s binding to the proteins on the
blot.
We used affinity chromatography to enrich the four
proteins that interact with YA specifically (P35, P25, P12,
and P10) (see Materials and Methods). We obtained enough
P35 for N-terminal sequencing; we did not pursue the other
three proteins further in this study. The N-terminal se-
quence of P35 was determined (Fig. 2A). Of the 20 amino
acids that the Cornell sequencing facility was able to
identify, 14 were unambiguous; there was uncertainty in 6
due to the limited amount of sample. The unambiguous
sequence was used to search the Drosophila genome (Ad-
ams et al., 2000). There was only one match—Drosophila
P0/AP3 (Fig. 2A), an apyrinic/apurimidinic endonuclease
that is also a ribosomal protein (Yacoub et al., 1996); we
will abbreviate this protein as P0. Four amino acids do not
match the P0 genomic sequence reported by Adams et al.
(2000); these mismatches are not due to strain differences
based on genomic PCR from the strain we used for protein
purification (data not shown); we therefore believe they are
due to machine error given to the limited amount of protein
available for sequencing. The first amino acid, Met, is in the
FIG. 1. Four cytoplasmic protein bands bind specifically to YA.
Cytoplasmic extracts of 0- to 2-h embryos were incubated with
either MBP-HMK-YA-coupled beads (Tag-YA) (lanes 2– 4) or MBP-
HMK-coupled beads (Tag) (lane 1) in the presence or absence of
competitor MBP-HMK-YA or MBP-HMK. The proteins eluted from
the beads were analyzed by blot overlay assays. Probes were either
32P-labeled MBP-HMK-YA (Tag-YA) or 32P-labeled MBP-HMK (Tag)
with a 4000-fold excess of unlabeled MBP-HMK. Shown in this
autoradiograph, when probed with 32P-labeled MBP-HMK-YA (top),
three proteins, P35, P12 and P10, bound to MBP-HMK-YA beads
only (lane 2). P25 bound to MBP-HMK-YA beads strongly and to
MBP-HMK beads very weakly (lanes 1 and 2). Two proteins, P42
and P30, bound to both MBP-HMK beads and MBP-HMK-YA beads
(lanes 1 and 2). The binding of all six proteins to MBP-HMK-YA
beads was competed by MBP-HMK-YA (lane 3); the remaining
residual binding is probably due to the incomplete competition by
MBP-HMK-YA competitor; their binding was not competed by
MBP-HMK (lane 4). The proteins were not labeled in a similar blot
probed with 32P -MBP-HMK (bottom), suggesting that the signals
on the 32P -MBP-HMK-YA probed blot are from the proteins’
binding to YA. DF, dye front. The proteins’ molecular weights are
42, 35, 30, 25, 12 and 10 kDa.
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predicted P0 sequence but not in the sequence of P35. Since
the P0 sequence is derived by conceptual translation from
the cDNA, this suggests that this Met is cleaved from the
protein after translation in vivo (Bradshaw et al., 1998).
Four lines of evidence support the conclusion that P35 is
Drosophila P0. First, the predicted molecular weight of P0
(34 kDa) and the size of its in vitro translation product
(Kelley et al., 1989) are the same as the size of P35 (35 kDa).
Second, affinity-purified anti-P0 antibodies (Yacoub et al.,
1996) cross-react with a band that migrates at the same
molecular weight as P35 and on Western blots parallels the
distribution of P35 during purification (Fig. 2B). Third,
purified recombinant P0 protein binds to YA directly in
vitro (Fig. 3). His6-tagged P0 was made and purified from E.
coli and incubated with MBP-HMK-YA or MBP-HMK.
Amylose beads were added to pull down the MBP-HMK
fusion proteins (see Materials and Methods). P0-His6 was
pulled down by amylose beads with MBP-HMK-YA, but not
with MBP-HMK, indicating that P0 binds specifically to the
YA moiety of MBP-HMK-YA. Finally, YA interacts with
Drosophila P0 in the yeast two-hybrid system as seen with
both qualitative and quantitative assays (Table 1). These
data, taken together, indicate that the YA-interacting pro-
tein P35 is Drosophila P0.
P0 and YA Are Members of a Complex in Both
Embryo and Ovary Cytoplasmic Extracts
P0 is an abundant multifunctional protein that is ex-
pressed throughout Drosophila development, and is re-
ported to be found in both nuclear and cytoplasmic subcel-
lular fractions (Yacoub et al., 1996). We confirmed that it is
abundant in the cytoplasm of 0- to 2-h embryos (Fig. 4).
To further examine the interaction of YA and P0 in
embryos and ovaries, we performed coimmunoprecipitation
assays with embryo and ovary cytoplasmic extracts (Fig.
5A). In the presence of affinity-purified anti-P0 antibodies,
YA was precipitated with P0 from both ovarian and embryo
cytoplasm (Fig. 5A, lanes 2 and 4). Immunoprecipitation
FIG. 2. P35 is Drosophila P0. (A) The N-terminal sequence of P35
purified from MBP-HMK-YA column aligned with the N-terminal
sequence of Drosophila P0/AP3, a ribosomal protein that also has
apurinic/apyrimidinic endonuclease activity (Yacoub et al., 1996).
The residues in lowercase are those for which the sequencing
facility reported uncertainty. (B) Western blot of embryo cytoplas-
mic proteins that passed through an MBP-HMK coupled column
and were loaded onto a MBP-HMK-YA column (ft1), the flow
through from the MBP-HMK-YA column (ft2), the wash (wash), and
the eluate from the MBP-HMK-YA column with increasing con-
centrations of NaCl (elution). The fractions separated by SDS–
PAGE were probed with anti-P0 antibodies. These antibodies
recognize P35, the 35-kDa band that bound to MBP-HMK-YA. The
ft1 and ft2 lanes each contain 0.5 U of extracts (Fisher et al., 1982);
the other lanes each contain 20 U of extracts.
FIG. 3. P0-His6 binds specifically to YA in vitro. A total of 2 g of
MBP-HMK (Tag-YA) or MBP-HMK (Tag) was incubated with 4 g
of P0-His6 and pulled down with amylose beads. All of the
supernatant (Sup.) and half of the proteins bound to beads (Beads)
were analyzed by Western blotting with anti-P0 antibodies. P0-His6
was pulled down with MBP-HMK-YA (lane 3) but not with MBP-
HMK (lane 4).
TABLE 1
Interaction of YA and P0 As Measured by the Yeast
Two-Hybrid Assay
Genes fused to pGBT9/
Genes fused to pGAD424 -Gal color -Gal activity (U)
YA/none All-A White 0.00638
YA/P0 All-A Light blue 0.184
YA/lamin All-A Blue 2.693
YA/none All-E White 0.141
YA/P0 All-E Light blue 0.671
YA/lamin All-E Blue 3.538
Note. Full-length Ya cDNA with mutations in all potential
MAPK phosphorylation sites to alanine (All-A) or to glutamic acid
(All-E) were cloned into pGBT9 vector. The resulting construct was
cotransfected with pGAD424 (the negative control), pGAD424-P0,
or pGAD424-lamin (the positive control). -Gal color and liquid
assays were performed with each cotransfection.
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with preimmune serum did not precipitate either P0 or YA
(Fig. 5A, lanes 3 and 5), indicating that the precipitation of
YA and P0 is specific to anti-P0 antibodies. The YA and P0
bands were also not from anti-P0 antibodies or the protein
A beads used for immunoprecipitation, since immunopre-
cipitation of buffer alone with anti-P0 antibodies showed
neither of the bands (Fig. 5A, lane 1). This indicates that YA
and P0 are in the same protein complex in both ovarian and
embryo cytoplasmic extracts. The ratio of YA to P0 is
similar in immunoprecipitates from ovary and embryo
cytoplasmic extracts; however, in the supernatants, the
ratio of YA to P0 is much higher in embryo samples than in
ovary samples, suggesting that there is more YA unassoci-
ated with P0 in embryos than in ovaries. Since P0 is more
abundant than YA, we interpret the higher level of P0-free
YA in embryos to mean that embryo YA has a lower affinity
for P0 than ovary YA, rather than that there is only limited
availability of P0 in embryos.
In the converse immunoprecipitation experiment, incu-
bation of cytoplasmic extracts from embryo with affinity-
purified anti-YA antibodies also precipitated both YA and
P0. As shown in Fig. 5B, anti-YA antibodies precipitated
both P0 and YA from wild-type extracts, but it precipitated
neither YA nor P0 from cytoplasmic extracts of embryos
whose YA was a truncated mutant form that is not recog-
nized by the anti-YA antibodies we used (Lin and Wolfner,
1991; Liu et al., 1995).
We used sucrose density gradient analysis to further
confirm that YA and P0 are in the same protein complex in
cytoplasmic extracts. Though P0 is distributed in all frac-
tions, its abundance peaks in the same gradient fractions as
YA’s in the gradient (highest amount in fraction 8 and
slightly less in fraction 9), consistent with the conclusion
that YA and P0 are members of a complex. This complex
migrates at 20S in the sucrose gradient (Fig. 6). Although P0
is predicted based on its sequence to be a component of the
large ribosomal subunit (Grabowski et al., 1991), the 20S
complex that contains P0 and YA is not a ribosomal
subunit; it is smaller than even the small ribosomal subunit
(40S). Moreover, another Drosophila ribosomal component,
DS3 (Wilson et al., 1994), did not comigrate with this 20S
complex (data not shown). Together with the coimmuno-
precipitation experiments, these results strongly suggest
that YA and P0 are present in the same protein complex in
vivo, in both embryos and ovaries, and that ovarian YA is
FIG. 5. YA and P0 coimmunoprecipitate from cytoplasmic ex-
tracts. (A) YA coimmunoprecipitates with P0 from cytoplasmic
extracts of both ovaries and 0- to 2-h embryos. Affinity-purified
anti-P0 antibodies, or preimmune serum (PreI), were added to
ovarian (Ov) (40 ovaries) or embryo (Emb) (5 l) cytoplasmic
extracts. The antibodies were then pelleted with protein
A-Sepharose 4B beads. Half of the proteins bound to the beads
(Pellet) and 1/20 of the supernatant after binding (Sup.) were
analyzed by Western blotting with anti-YA antibodies (YA) or
anti-P0 antibodies (P0). The YA doublet was precipitated with P0
by anti-P0 antibodies (lanes 2 and 4) but not by preimmune serum
(lanes 3 and 5). The signals in the preimmune serum lanes are not
YA, as they are also present in preimmune serum not incubated
with extracts (data not shown). The ratio of YA to P0 in the pellet
is similar between ovary and embryo samples, but higher in
embryo supernatant samples than in ovary supernatant samples. (B)
P0 coimmunoprecipitates with YA from embryo cytoplasmic ex-
tracts. Cytoplasmic extracts from 5 l of packed 0- to 2-h wild-type
(WT) or Ya2 mutant (Ya2) embryos were incubated with anti-YA
antibodies and pelleted with protein A-Sepharose 4B beads. The
eluate from the beads (Pellet) and the supernatant after binding
(Sup.) equivalent to that from 1 l of embryos were analyzed with
Western blotting with either anti-YA antibodies (YA) or anti-P0
antibodies (P0). P0 was pulled down together with YA from the
wild-type embryo cytoplasmic extracts (lane 1), but not from the
Ya2mutant extracts whose truncated YA is not recognized and
pulled down by the anti-YA antibodies used (lane 2).
FIG. 4. P0 is abundant in embryo cytoplasm. Embryos at 0–2 h
were stained with affinity-purified anti-P0 antibodies. P0 levels are
high in the cytoplasm. Parallel staining of embryos with different
primary antibodies (anti-YA; data not shown) confirmed that the
cytoplasmic staining is not due to staining conditions or to
background from the secondary antibodies used. The bar denotes
100 m.
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likely to associate with this complex more strongly than
does embryo YA.
MAPK Phosphorylates YA in Vitro and This
Phosphorylation Increases Binding of YA to P0
The changes in YA’s phosphorylation state at a potential
MAPK and p34Cdc2 kinase site during egg activation sug-
gested that YA may be phosphorylated by MAPK or p34Cdc2
kinase in oocytes and dephosphorylated after the initiation
of egg activation (Yu et al., 1999). Therefore, we tested
whether YA can be phosphorylated by one or both of these
kinases.
Purified MBP-HMK-YA was incubated in vitro under
phosphorylation-permissive conditions with p34Cdc2 kinase
immunoprecipitated from mitotic Hela S3 cells, with
MAPK, or with both p34Cdc2 kinase and MAPK. As shown in
Fig. 7, MBP-HMK-YA was not phosphorylated in the pres-
ence of active p34Cdc2 kinase alone (Fig. 7, lane 1), but was
phosphorylated in the presence of MAPK alone and of both
kinases (Fig. 7, lanes 2 and 3). These results indicate that, in
vitro, YA is a substrate for MAPK but not for p34Cdc2 kinase.
We then tested whether phosphorylation of MBP-
HMK-YA by MAPK affects MBP-HMK-YA’s binding of P0.
Equal amounts of phosphorylated MBP-HMK-YA and un-
phosphorylated MBP-HMK-YA (from a “mock” phosphory-
lation reaction) were incubated with the same amount of
purified P0-His6. The complex was pulled down with amy-
lose beads. At 0.3 g, a concentration of MBP-HMK-YA
below saturation for binding, more P0 was pulled down
together with phosphorylated MBP-HMK-YA (Fig. 8, lane 3)
than with unphosphorylated MBP-HMK-YA (Fig. 8, lane 4).
This indicates that MAPK phosphorylated YA binds more
strongly to P0 than unphosphorylated YA in vitro.
Decreased P0 Levels Partially Suppress a
Hypomorphic YA Mutant Allele
For further confirmation of interaction between YA and
P0, we examined the genetic interaction between YA and
P0. We examined the effect of maternal heterozygosity for a
P0 null allele P0306 (Frolov and Birchler, 1998) on embryos
from females homozygous for the hypomorphic Ya77 muta-
tion (“Ya77 embryos”). Ya77 embryos are classified into three
categories based on their arrest phenotype (Liu et al., 1995).
Pronuclear arrest embryos are arrested at the pronuclear
stage at the end of meiosis. This is the most severe
FIG. 6. YA and P0 are present in a 20S complex in cytoplasm. Cytoplasmic extracts from 0- to 2-h embryos were loaded onto a 5–35%
sucrose density gradient. Fractions were analyzed by Western blotting with anti-YA antibodies (YA; top panel) and anti-P0 antibodies (P0;
bottom panel). Both YA and P0 peaked at fraction 8 in the density gradient. This fraction is 20S, based on the size markers run at the same
time (data not shown). In addition to their comigration in a 20S complex, YA and P0 appear to also be found (separately) in other complexes.
FIG. 7. YA is phosphorylated by MAPK but not by p34Cdc2 kinase.
Purified MBP-HMK-YA was incubated with p34Cdc2 kinase immu-
noprecipitated from mitotic Hela cell lysate, MAPK, or both
kinases in the presence of [-32P]ATP. The kinase reactions were
analyzed by SDS–PAGE and autoradiography. MBP-HMK-YA was
not phosphorylated by p34Cdc2 kinase (lane1). The lack of signal in
this lane is not due to inactivity of the kinase, since the parallel
positive control reaction showed histone H1 being phosphorylated
by p34Cdc2 kinase (lane 4). MBP-HMK-YA was phosphorylated by
MAPK in the absence or presence of p34Cdc2 kinase (lanes 2 and 3).
Phosphorylation of MBP-HMK-YA by MAPK is due to phosphory-
lation of the YA moiety and not of the MBP-HMK moiety, since the
60-kDa MBP-HMK-containing degradation product in the MBP-
HMK-YA preparation is not labeled.
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phenotype. Type II embryos escape the pronuclear arrest
and undergo a few of rounds of nuclear division before
arresting. Type I embryos are thought to be degenerating
from pronuclear or type II arrests. As shown in Table 2,
lowering the P0 level by half (P0306/) partially but signifi-
cantly (P  0.02) suppressed the Ya77 phenotype. Fewer
embryos from X∧X, y Ya77 cv v f/Y; P0306/mothers arrested
at the pronuclear stages than those from control X∧X, y Ya77
cv v f/Y; /MKRS mothers, and more embryos escaped the
pronuclear arrest and underwent a couple of rounds of
division (Type II). This suggests that P0 normally functions
to antagonize YA function, consistent with our proposal
that P0 functions to keep YA out of nuclei, where YA
functions. Heterozygous P0 null females are fertile, suggest-
ing that half the normal dose of P0 is still enough to retain
hyperphosphorylated YA in the cytoplasm of oocytes.
DISCUSSION
The subcellular location of YA proteins is modulated
during development; this correlates with changes in YA’s
phosphorylation state, including at one putative MAPK
target site (Yu et al., 1999). In this study, we showed that
four proteins from cytoplasmic extracts bind to YA directly
in vitro and identified one of them as Drosophila P0/AP3.
Our observations here that the cytoplasmic protein P0/AP3
associates with YA in a 20S complex in the cytoplasm and
that this association is stronger when YA has been phos-
phorylated by MAPK suggest the following model (Fig. 9):
During oogenesis, YA is synthesized from maternal mRNA
and phosphorylated by MAPK in the developing egg cham-
ber. This phosphorylation causes more YA to be retained in
a 20S cytoplasmic complex that serves to retain YA outside
of nuclei. Upon egg activation, YA is partially dephospho-
rylated, including at one MAPK site. This dephosphoryla-
tion decreases YA’s retention by the 20S complex. Those
YA molecules released from the complex are freed to enter
nuclei via their NLS. The future purification and identifi-
cation of the other three cytoplasmic proteins that bind to
YA will identify their roles in the retention of YA during
development. Our data from in vitro assays (affinity chro-
matography, blot overlay, and pull-down) and from yeast
two-hybrid analysis are consistent with this model. The
coimmunoprecipitation and the sucrose density gradient
experiments with cytoplasmic extracts strongly argue that
FIG. 8. MAPK phosphorylation increases YA’s binding to P0. A total of 4 g of MBP-HMK-YA was incubated with p34Cdc2 kinase and
MAPK as in Fig. 7; an equal amount of MBP-HMK-YA was incubated in a parallel “mock” reaction from which the kinases were omitted.
Then, 3 g of P0-His6 was incubated with 0.7 or 0.3 g of phosphorylated YA (P) or unphosphorylated YA (from the mock reaction; UnP).
Amylose beads were then added to pull down the complexes containing MBP-HMK-YA. 1/25 of the supernatant after binding (Sup.) and half
of the proteins eluted from the beads (Beads) were analyzed by Western blotting probed with anti-YA antibodies or anti-P0 antibodies. A
total of 0.7 g of phosphorylated or unphosphorylated MBP-HMK-YA pulled down similar amount of P0 (compare lanes 1 and 2, P0 panel),
indicating that this concentration is above saturation for binding. As YA becomes limiting, difference in affinity are detectable: 0.3 g of
phosphorylated MBP-HMK-YA pulled down more P0 than 0.3 g of unphosphorylated MBP-HMK-YA (compare lanes 3 and 4, P0 panel).
TABLE 2
Lowered P0 Level Partially Suppresses a Hypomorphic
Ya Mutant Allele
Genotype
Phenotype
Pronuclear
arrest Type II Type I
X^X, Ya77; P0306/
(n  158)
112 (70.9%) 7 (4.4%) 39 (24.7%)
X^X, Ya77; /MKRS
(n  105)
90 (85.7%) 2 (1.9%) 13 (12.4%)
Note. Embryos at 0–2 h from X^X, y Ya 77 cv v f/Y; P0306/ and
X^X, y Ya 77 cv v f/Y; /MKRS females were collected and stained
with DAPI. Embryos were scored for their arrest phenotype accord-
ing to Liu et al. (1995). X^X, Ya 77 stands for X^X, y Ya 77 cv v f/Y.
2, 7.81; degrees of freedom, 2; P  0.02.
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YA and P0 are together in a complex in vivo and also
support this model. Our genetic analysis showing the
suppression of a weak Ya allele by lowered P0 dosage is also
consistent with the model.
This model has several implications for understanding
macromolecular events before and during egg activation.
Our data suggest that MAPK is active in meiosis-arrested
Drosophila oocytes. MAPK activity is known to increase
during oocyte maturation and remain high in meiotic
metaphase-arrested oocytes of, for example, Xenopus and
mouse (Colas and Guerrier, 1995; Russo et al., 1998), but to
our knowledge this has not been demonstrated in Drosoph-
ila. Yu et al. (1999) had shown that 443Thr, a potential
MAPK and p34Cdc2 kinase phosphorylation site in YA, is
phosphorylated in oocytes. Our results here show that
MAPK but not p34Cdc2 kinase can phosphorylate YA in
vitro. Taken together, these suggest that MAPK phosphor-
ylates YA in vivo in oocytes, which suggests that MAPK
activity will be detected in Drosophila oocytes, though
such activity could potentially be restricted in time or
place, as is the case for p34Cdc2 kinase in early Drosophila
embryos (Su et al., 1998). Because YA is not a target for
p34Cdc2 kinase in vitro, our data cannot address whether
MPF activity is high in meiotic metaphase-arrested oocytes
as it is, for example, in Xenopus (Gerhart et al., 1984; Masui
and Markert, 1971; Smith and Ecker, 1971).
Our data suggest that modulation of MAPK phosphory-
lation occurs during egg activation in Drosophila. Yu et al.
(1999) had shown that dephosphorylation of a potential
MAPK and P34Cdc2 target site, 443Thr, during egg activation
correlated with changes in YA’s subcellular location. That
YA is, at least in vitro, a target of MAPK but not p34Cdc2
kinase suggests that MAPK activity is modulated. It is
possible that modulation of MAPK phosphorylation is a
general regulatory mechanism during Drosophila egg acti-
vation, similar to other organisms. Future studies of other
proteins active or activated at this time in Drosophila
(Axton et al., 1994; Chen et al., 2000; Edgar et al., 1986;
Elfring et al., 1997; Fenger et al., 2000; Freeman and Glover,
1987; Freeman et al., 1986; Lieberfarb et al., 1996; Loppin et
al., 2000; Page and Orr-Weaver, 1996; Santamaria, 1983;
Santamaria and Gans, 1980; Shamanski and Orr-Weaver,
1991) will be useful in testing this.
YA may provide a link between MAPK activity and
regulation of chromosome condensation state. YA is likely
to be involved in modulating chromatin condensation dur-
ing the end of meiosis (Liu et al., 1995). It has been shown
in mice that chromosome condensation state follows
MAPK, but not MPF, activity during oocyte metaphase
arrest and egg activation (Verlhac et al., 1994). If the same
holds true for Drosophila, it would be tempting to postulate
that MAPK does so via its regulation of proteins that
modulate chromosome condensation, such as YA.
The exclusion of YA from nuclei prior to egg activation
(Yu et al., 1999), and its chromatin binding (Lopez and
Wolfner, 1997) and nuclear organization (Liu et al., 1995)
functions, might suggest that exclusion of YA from nuclei
might be essential for oogenesis. Perhaps it is important to
exclude from meiotic nuclei a protein that is needed for
postmeiotic chromatin remodeling, in order not to interfere
with meiotic chromosome condensation. If this were the
case, then disabling potential phosphorylation sites that
control YA’s subcellular location during development
should result in meiotic arrest. Our finding here that YA is
a target of MAPK makes it possible to test this hypothesis.
We identified a 20S cytoplasmic complex that contains
YA and P0 and that we propose serves to retain YA in the
cytoplasm in response to developmental signals. Modula-
tion of a protein’s interaction with a cytoplasmic protein is
one of the modes in which phosphorylation regulates a
protein’s nuclear entry (Jans and Hubner, 1996). The
nuclear entry of NF-B and Dorsal have been shown to be
regulated in this fashion (Drier et al., 1999; Li and Sedivy,
1993; Whalen and Steward, 1993). It will be interesting to
see whether the 20S cytoplasmic complex that includes YA,
or other analogous complexes, regulates the subcellular
location of other Drosophila maternal proteins before and
during egg activation.
The molecular events leading to and during Drosophila
oocyte metaphase arrest and egg activation are not yet well
understood. Our identification of an interaction between
YA and P0, and its capacity for regulation by MAPK, points
to the involvement and regulation of MAPK activity in
these critical developmental processes. This regulation of
YA’s subcellular localization, and hence its ability to access
chromatin where it could potentially sense or modulate
condensation, could suggest a mechanism for MAPK’s role
in the regulation of chromosome condensation state at this
critical developmental time in Drosophila.
FIG. 9. A model for the regulation of YA’s nuclear entry during
development by the 20S cytoplasmic complex. Hyperphosphory-
lated YA in ovaries is more strongly retained in the 20S complex
and is kept completely in the cytoplasm. Partially dephosphory-
lated YA in activated eggs and in embryos is less strongly retained
in the cytoplasmic complex, so some YA dissociates from the
complex and is free to enter nuclei using its NLS.
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